✦ LIBER ✦

HMGA2 and high-grade serous ovarian carcinoma

✍ Scribed by Jingjing Wu, Jian-Jun Wei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences of chemoresistance assay bet

✍ A. SANTILLAN; Y.W. KIM; M.L. ZAHURAK; G.J. GARDNER; R.L. GIUNTOLI II; I.M. SHIH; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Origin and molecular pathogenesis of ova

✍ Kurman, R. J. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 101 KB

The diagnostic utility of TP53 and CDKN2

✍ Altman, Alon D; Nelson, Gregg S; Ghatage, Prafull; McIntyre, John B; Capper, Dav 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 441 KB

HMGA2 protein expression in ovarian sero

✍ Hetland, Thea Eline; Holth, Arild; Kærn, Janne; Flørenes, Vivi Ann; Tropé, Claes 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 397 KB

Ovarian low-grade serous carcinoma: A co

✍ Ivan Diaz-Padilla; Anais L. Malpica; Lucas Minig; Luis M. Chiva; David M. Gershe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 613 KB

Genomic analysis of genetic heterogeneit

✍ Cooke, S L; Ng, C K Y; Melnyk, N; Garcia, M J; Hardcastle, T; Temple, J; Langdon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 622 KB